Bolt Biotherapeutics, Inc. (BOLT) Social Stream
Bolt Biotherapeutics Inc (BOLT) Price Targets From Analysts
Use the tables below to see what analysts covering Bolt Biotherapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
BOLT's average price target has moved down $14.5 over the prior 136 days.
BOLT reports an average of 249.87% for its upside potential over the past 41 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BOLT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 92 days, BOLT's average broker recommendation rating worsened by 0.75.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BOLT as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Bolt Biotherapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 787.16% of them.
- To contextualize these metrics, consider that out of all US stocks, Bolt Biotherapeutics Inc's variance in analysts' estimates is lower than -537.38% of them.
- In terms of how Bolt Biotherapeutics Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 142.7% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Bolt Biotherapeutics Inc's average analyst price target is greater than 493.78% of them.
Make investment decisions regarding BOLT using the data that counts. Try POWR Ratings for free.